BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3509365)

  • 1. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
    Monaci E; Monaci R; Giacalone G; Meoni S
    Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of 89,517 gram-negative isolates to aztreonam and other antibiotics.
    Lindsay G; Woods P
    Chemioterapia; 1987 Jun; 6(2 Suppl):106. PubMed ID: 3509363
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
    Soussy CJ; Le Van Thoi J; Duval JR
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aminoglycoside activity in relation to gram-negative microflora isolated from heart surgery patients].
    Ostrovskaia EA; Khaimova MD
    Antibiotiki; 1983 Sep; 28(9):693-8. PubMed ID: 6638983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies with aztreonam, a new monobactam antibiotic.
    Peddie BA
    N Z Med J; 1986 Apr; 99(799):249. PubMed ID: 3458073
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
    Kafetzis DA; Legakis NJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):110-2. PubMed ID: 3151330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enzymatic mechanisms of resistance to aminoglycoside antibiotics in gram negative bacilli from Chilean hospitals].
    Del Solar E; García A; Bello H; Domínguez M; González G; Zemelman R
    Rev Med Chil; 1995 Mar; 123(3):293-7. PubMed ID: 8525167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of Ro 17-2301, a new monobactam antibiotic].
    Roy C; Foz A; Segura C; Tirado M; Teixell M
    Med Clin (Barc); 1985 Jun; 85(5):183-6. PubMed ID: 3927089
    [No Abstract]   [Full Text] [Related]  

  • 19. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminoglycosides, imipenem, and aztreonam.
    Johnson JG; Hardin TC
    Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.